Introduction
Kaposi's sarcoma (KS) was rare when first described by Moritz Kaposi (1872) in Europe (1) . It is now recognized to be pathognomonically associated with the novel human herpesvirus type 8 (HHV-8) also known as Kaposi's sarcomaassociated herpesvirus (KSHV) (2) , and has become the most important HIV/AIDS-associated malignancy in various subSaharan countries including Tanzania in terms of frequency, morbidity and mortality (2) (3) (4) . The frequency of HIV/AIDS KS (AKS) in comparison with endemic KS (EKS) continues to increase with the HIV epidemic and oral KS (OKS) is recognized as a frequent manifestation of AIDS (5,6) but little studied in Africa including Tanzania. The presence of HHV-8 latency-associated nuclear antigen (LANA) is known to discriminate KS from non-KS tumours by immunohistochemistry (IHC) with high sensitivity and specificity and is therefore comparable to real-time polymerase chain reaction (PCR) for evaluation of KS tissues (7, 8) . However, tissue-based IHC/immunofluorescence (IFA) studies on oral KS are apparently, lacking and reports on KS proliferative activity are few, limiting evaluation of their pathogenesis and possible formulation of preventive and therapeutic protocols (4, 6, 7, 9, 10) . Most documented KS immunohistochemistry (IHC) studies were performed on cutaneous biopsies, while reports on oral cases mainly concerned molecular studies of buccal swabs and saliva (4, 6, 7, 9, 10) . Tissue differences in tumour cell proliferation and HHV-8 cell association (content) in terms of viral load (PCR) and LANA expression with increasing KS tumour stage have been reported previously (4, 11) but no comparison between sexes and age-groups and between OKS and cutaneous KS are documented. Demographically, KS was previously related mostly to males (homosexuals, bisexuals and IV drug addicts) in developed and developing countries which suggested a possible biological gender or sexual behaviour relatedness (4, (12) (13) (14) . However, the continuous narrowing of male to female ratio and high AKS frequency in female sex workers and sexually transmitted disease (STD) patients in sub-Saharan Africa seem to indicate the importance of a sexual route of KSHV/HHV-8 transmission (15, 16) . HHV-8/KSHV has been found in oral (saliva) (5, 9, 17) and genital (semen and cervical/vaginal) fluids (5, 12, 18) suggesting an important role for genital-oral and oral-oral HHV-8 transmission in KS development (17) (18) (19) . Anatomical studies of OKS reported the palate, gingiva and tongue as commonly affected sites (6, 20) . OKS appears prognostically less favourable than cutaneous forms (20) suggesting differences in susceptibility of mucosal and other tissues although few African data are available (14, 17) . The present study further elucidates viral and cell biological aspects of oral KS in order to allow formulation of preventive and therapeutic strategies.
Materials and methods
Biopsies. Archival formalin-fixed, paraffin-embedded (FFPE) diagnostic biopsies and corresponding medical records of 78 Tanzanians with oral KS, processed at the Department of Histopathology, Muhimbili National Hospital (MNH)/Muhimbili University College of Health Sciences (MUCHS) in Dar es Salaam between 1990 and 2005 were retrieved and further evaluated at the Immunopathology Lab, Karolinska Institute, Stockholm. Of these, 29 oral KS (OKS) biopsies were selected with regard to tumour content of 40-90%, minimal necrosis/haemorrhage, and diagnostically clear nodular or plaque histology but not patch KS for immunofluorescence (IFA) studies of HHV-8 LANA cell association and tumour proliferation as Ki-67 expression. These cases were compared with 21 cutaneous KS biopsies matched to the OKS cases for age, sex, HIV and HHV-8 serostatus, histological grade, tissue block size (quantity of biopsy), section size, tumour content and degree of haemorrhage and necrosis. Furthermore, an unmatched comparison across genders, age-groups and anatomical (oro-cutaneous) presentation was performed. None of the patients included in this study had received any antiretroviral (ARV) or tumour therapy before the biopsy was taken.
Histological evaluation. Biopsy sections (5 μm) were deparaffinized (in xylene), stained with haematoxylin and eosin (H&E) (21) and reviewed independently by three Pathologists (ARM, EEK and PB) who also selected biopsies for IFA.
Immunohistochemistry. Briefly, deparaffinized sections (5 μm) were taken through descending grades of alcohol, and heated in a microwave at 750 W for 6 min after boiling point in 0.1 M citrate buffer (pH 6.0) for antigen retrieval. After cooling (30 min) at room temperature (RT), quenching of endogenous peroxidase was performed by treatment with 30% hydrogen peroxidase in distilled water (30 min at RT) before avidinbiotin immunoperoxidase (ABC) staining, as previously described (11, 21) . Sections were also immunostained with triple-marker IFA for LANA, CD34 [endothelial/KS spindlecell (SC)] and Ki-67 markers (Table I) as previously described (11) . Number of positive cell nuclei per section was evaluated after staining for DNA with 6-diamidino-2-phenylindole (DAPI) solution (10 μM DAPI in 800 mM disodiumhydrogenphosphate) ( Microscopy. Photomicroscopy (Olympus BX60, Tokyo, Japan) with a digital camera (Sony DKC-5000, Tokyo, Japan) and different filters for fluorescence microscopy was used to document bright fields as well as specific FITC, Cy3, Cy5, and DAPI fluorescence images which were edited and overlaid using Adobe 
Serology
HIV serology. HIV-1 evaluation was performed (Department of Microbiology/Immunology MUCHS) on KS sera by double-ELISA assays (serial) as previously described (22, 23) .
HHV-8 serology. HHV-8 serology was carried out on available oral KS patient sera at the Swedish Institute for Infectious Diseases Control, Stockholm, by IFA for antibodies to HHV-8 antigens using two B-cell lines (BCP-1 and BCBL-1) infected with HHV-8 as previously described (12) .
Immunology. CD4, CD8 lymphocytes, and total white blood cell counts (WBCC) of OKS patients were evaluated (Department of Microbiology/Immunology MUCHS) using Immuno-flow cytometry (MicroDif 18 Coulter CounterCoulter Electronics, Luton, London, UK) as previously described (24) . The cut-off point for normal WBCC in Tanzania was at 4.5x109 as previously described (24) but the study designated cut-off point for immuno-deficiency was a CD4/CD8 ratio <0.5 (or CD4 counts <200 T-cells/μl) and 0.1 (CD4 counts <50 T-cells/μl) for severe immunodeficiency.
Statistical analysis
The EPI INFO 6 statistical software programme (CDC, Atlanta, GA) and Microsoft Excel (Microsoft Corporation, Redmond, WA, USA) were used. The p-values of ≤0.05 were considered statistically significant. Comparison of normally distributed sample means was performed using analysis of variance (ANOVA) while nonparametric (Kruskal-Wallis) tests and the Fisher exact test were used to analyze smaller sample sizes. Furthermore, medians rather than means were used to express and compare central tendency in small samples.
Results

Demography.
A total of 78 oral KS cases, 24 males (30.8%) and 54 females (69.2%) were collected (male to female ratio≈1:2) out of approximately 700 KS (11.1%) biopsies from 465 males and 235 females (male to female ratio≈1:2) of which 488 were AKS (69.7%), 100 were EKS (16.0%) and 112 were of unknown HIV status registered between 1990 and 2005. The median age for OKS males and females (p-value =0.03) was 38 and 31 years respectively (Table II) . Five OKS patients (6.7%) were children (<15 years) and 3 (4.0%) were middle-aged (≥50), thus most cases (93.3%, 70/75) represented the sexually most active age-group (15-49), with a peak frequency at age 25-35 years (58.7%, n=44/75).
Clinical presentation. Most patients (46/78, 59.0%) presented with primary, clinically localized OKS but a greater proportion (50.0%) of males than females (37.0%) presented with disseminated KS at first diagnosis (Table II) . The clinical records seem to indicate that males were 4-times more likely to have multicentric OKS than females. Palatal KS lesions (Fig. 1a) were most frequent (55.1%, 43/78) followed by the tongue (Fig. 1b) (25.6%, 20/78) whereas buccal mucosa (23.1%, 18/78), and other sites (tonsils, oropharynx) were rare. All patients (n=6) with concurrent opportunistic infections [pulmonary tuberculosis (4/6) and oral thrush (2/6)] were females. Haemorrhage was a presenting symptom in 6.4% (5/78) patients while 3.8% (3/78) had fungating lesions.
Serology and immunology.
ELISA studies on all (78) OKS sera showed that 74 (94.9%) were seropositive for HIV (AKS) and 4 (5.1%) cases were negative (EKS). Available (34) OKS sera (33 AKS, 1 EKS) which could be screened by IFA microscopy for anti-HHV-8 antibodies were positive. All (21) cutaneous KS selected for matched immunohistology studies were HIV and HHV-8 seropositive. Cell counts (FACS) of available (31) OAKS patient blood showed that 25 (80.7%) had CD4 values <10 T-cells/μl and none >50 T-cells/μl. Concordantly, most patients (24/31) (77.4%) had a CD4/CD8 ratio <0.1 implying severe immunodeficiency. Table I . Antibodies (Ab) used in stainings by immunofluorescence and/or peroxidase. - 
Early KS = patch + plaque stage. a Not included in the immunohistology study. Tables III and IV and Fig. 2a-d . All KS biopsies were positive for LANA (Fig 2a and b) , CD34 ( Fig. 2b and d) and Ki-67 ( Fig. 2c and d ) markers but nodular OAKS in adult males had more LANA + cells (median =67.6%) than females (40.4%), a statistically significant difference (p-value =0.02) although the number of adult males with nodular OAKS was small (Table III) . Similarly, LANA + granules/nucleus in adult nodular OAKS showed a somewhat higher median value in male (18.5 gr/n) compared to female (10.0 gr/n) biopsies although not statistically significant (p-value =0.086). Concordantly, biopsies from adult male nodular oral AKS had more (median =64.9%) LANA + /CD34 + [KS spindle-cells (SC)] per HPF compared to females (45.9%), a statistically significant difference (p-value =0.03) (Table III) . A gender difference was also observed with regard to tumour cell proliferation in adult OAKS with a statistically significant (p-value =0.04) difference in mean Ki-67 + cell frequency for males (23.5%) and females (18.0%) (Table III) . This was apparent also from evaluations of proliferating (Ki-67 + ), HHV-8 infected (LANA + ) SC (CD34 + ) cells (triple positive cells) which were statistically significantly higher in male (median =19.3%) than in female nodular OAKS (median =9.5%) (p-value =0.02) (Table III) . Furthermore, the frequency of triple-positive cells was also found to be significantly higher in male (median =17.6%, mean =20.4%) than in female OAKS (median =10.1%, mean =11.2%) in unmatched biopsies (p-value =0.03) (Table IV) . Moreover, an apparent correlation (R 2 =0.56 or 56%) was found between LANA and Ki-67 immunoreactivity in adult OAKS biopsies, particularly with regard to LANA + /CD34 + SC (R 2 =0.59 or 60%) (Fig. 3) . IFA also showed cell count differences between children <15 and adults ≥15 years respectively (Table III and Ki-67 + cell counts and also higher median LANA + granule counts (Table III and IV) . Moreover, the median Ki-67 + count also appeared higher in children (22.8%) than adult (17.2%) nodular OAKS with an almost statistically significant difference (p-value =0.06) (Table III) . No children with cutaneous AKS (CAKS) biopsies were available for comparison.
Comparison of nodular OAKS and CAKS showed that LANA + cells were significantly (p-value =0.03) more frequent both in matched (Table III) and unmatched biopsies (Table IV) . Also, LANA + /CD34 + SC appeared to be more frequent in nodular OAKS than CAKS although the difference was not statistically significant (Tables III and IV). CD34 + , Ki-67 + as well as triple-positive (LANA + /CD34 + /Ki-67 + ) cells, were more frequent in nodular OAKS than in CAKS (Tables III  and IV) , with high statistical significance (p-value =0.002, 0.00003 and 0.0002 respectively).
Discussion
Oral KS (OKS) particularly in HIV patients (OAKS) has been reported in Africa, Europe and America but less in Asian populations (13, 14, 25, 26) and the present cohort of 78 OKS corresponds to approximately 11% of all (700) KS cases collected at MUCHS/MNH from 1990-2005. These OKS showed a high (84.6%) HIV association consistent with the notion that OKS is an important clinical indicator for AIDS 
OAKS), (B) juvenile vs adult OAKS and (C) OAKS vs cutaneous HIV/AIDS Kaposi's sarcoma (CAKS). -----------------------------------------------------------------------------------------------------
-values ----------------------------------------------------------------------------------------------------------------A. (21 biopsies)
Adult male nodular OAKS (4) Adult female nodular OAKS (17) -------------------------------------- - (12,27,28). In Canada, OKS was reported to constitute approximately 2% of KS cases where it was identified as the first malignant diagnosis in AIDS patients (29) . A South African (SA) study reported a total of 81 OKS cases collected during 1973-2002 of which 68 (84%) cases occurred after 1997 reflecting a marked increased frequency of the HIV epidemic (6) . However, these hospital-based figures are prone to selection bias and not very representative for the general populations, thus limiting comparability. Nevertheless, our findings suggest a comparatively high frequency of OKS in Tanzania.
The apparent predominance of females [male:female ratio =1:2.3] in this Tanzanian OKS cohort, is obviously in contrast with the usual male KS predominance reported previously (4, 6, (12) (13) (14) . Although the reasons for this female OKS predominance are not clear and may include a recruitment bias, it is noteworthy that other reports from East Africa have recorded a dramatic male:female ratio decline (11-fold) in KS from 19:1 (1960-71) to 1.7:1 (1991-97) (15, 16, 30) . This is also supported by findings of an even lower male:female ratio of 1.3:1 amongst patients with OKS in SA (6) . In Zimbabwe however, a male:female ratio of 3:1 for OAKS and 4:1 for other oral HIV manifestations were recently recorded and more similar to Western reports where gender distribution is influenced by a relatively high frequency of KS among homosexuals (13,14) . The gender differences in KS are of interest considering previous suggestions of lower female risk, possibly attributed to hormonal factors including human chorionic gonadotropin (hCG)-in pregnant women (1, 31, 32) , although some reports disagree (30, 33) . Considering the well documented male:female ratio decline for AKS in Africa (including Tanzania) (15, 16, 30) it seems likely that this reflects ongoing changes in heterosexual behaviour since KSHV is known to be sexually transmissible (9,10). However, the peak age (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) of OAKS and the high frequency of patients aged 15-49 years in our study, is representative of the sexually active population and evidently suggests the association of sexual behaviour with OAKS development. Obviously, the age distribution of oral AKS in Tanzania also reflects that of the group most affected by the HIV epidemic. However, geographical (6, 13, 26, 29) , age (17, 34) and genderrelated (13, 14) variations may also be related to host (HLA, immunity) (17, 35) , environmental (35) factors and/or virological (HHV-8 and HIV subtypes) (36) and also to yet unknown differences in pathogenetic/biologic mechanisms.
The factors related to the apparently increased susceptibility of the palate over other buccal tissues to generate KS lesions are not known and may be rather complex (6, 27) . The fact that most OAKS in our cohort were localized lesions and mostly late-nodular stage suggests that OAKS may be a distinct clinical entity (6, 27) . ONCOLOGY REPORTS 17: 1291 -1299 , 2007 Table IV. Unmatched triple-IFA cell count comparison for (A) male vs female oral AIDS-related Kaposi's sarcoma (OAKS), (B) juvenile vs adult OAKS and (C) OAKS vs cutaneous HIV/AIDS Kaposi's sarcoma (CAKS). -
The apparently higher lesional HHV-8 content and tumour proliferation index (PI) (Ki-67 + cell frequency) in male than female lesions, as well as the predilection to systemic dissemination and multicentricity of oral lesions in males compared to females, agrees with the notion that KS is predominantly a male disease. Thus at the tissue level, males may be more susceptible to HHV-8 infection than females (4, (12) (13) (14) . Similarly, OAKS in children also had significantly more HHV-8 tumour cell association than adults which is in agreement with other African HHV-8 seroprevalence reports (34, 37) and may indicate, for unclear reasons, increased susceptibility in children (17, 34) and also emphasizes the importance of horizontal transmission (oral exposure) in families possibly initiated by vertical mother-to-child transmission (9, 34, 37, 38) . However, the small numbers of both male and children biopsies available in our cohort limit definitive conclusions. The apparent higher HHV-8 content and cell proliferation index (PI) in oral than cutaneous AKS (CAKS) also indicates that the oral cavity is an important portal of entry and reservoir for HHV-8. In contrast, the skin, although most often the primary site of KS, appears a less important route of transmission (9, 18, 19) . Our findings of a significantly higher PI in oral than cutaneous KS are supported by other observations based on skin KS (4,39) and the observed (60%) correlation between tumour PI and LANA + /CD34 + SC appears to indicate that tumour cell (SC) proliferation is partly viral (HHV-8)-induced and that virus accumulation therefore is due to the proliferation of HHV-8-infected SC. However, tumour growth appears also dependent on the recruitment of uninfected progenitor cells (4, 40) . In previous studies, we have shown that total cell PI was higher in early than late CAKS lesions and not significantly different between nodular AKS and EKS (4) but comparison of oral vs cutaneous and juvenile vs adult KS as in the present study, was not previously reported (4, 39) . The findings of higher PI in male vs female, children vs adults and oral vs cutaneous KS correspond with HHV-8 LANA results and appear indicative of a less favourable pathogenesis for OKS in general, and in males and children in particular which entertains the notion of greater disease burden in males (4, 6, 20) . The observed differences in PI were clearly correlated with tissue KSHV/HHV-8 content. Furthermore, the fact that gender differences were most evident in the matched (nodular KS) group seems to indicate that they are dependent on tumour stage. Thus, the differences in gender, age-group and tissue affected found in the present study reflect the complex pathogenesis of KS development.
In conclusion, our study shows a) that oral Kaposi's sarcoma (OKS) is frequent (11%) among KS patients at the Muhimbili-National Hospital/-University College, Dar es Salaam, Tanzania; b) that OKS is highly associated with HIV infection and advanced (nodular) histological stage; c) that the HHV-8 lesional content (LANA immunoreactivity) is higher in nodular oral AIDS-related KS (AKS) lesions of males than females and of children than adults; d) that males appeared to have more tumour burden (multicentricity and systemization) although OKS frequency among females is seemingly higher; and (e) oral AKS had higher HHV-8 content than cutaneous AKS which appeared correlated to tumoral proliferation index.
